On July 24, 2026, Tenet Healthcare Corp THC announced robust Q2 2026 results, showcasing significant growth in revenues and adjusted EBITDA. The company is also increasing its guidance for the year, despite facing challenges in payer mix and insurance enrollment.
- P/E ratio of 8.99x indicates a potentially undervalued stock compared to historical averages.
- GF Scoreā¢ of 79/100 suggests a strong position in terms of long-term performance potential.
- Insider activity shows $1.5 million in shares sold over the past three months, indicating some caution among insiders.
What's Behind the News?
Tenet Healthcare's Q2 2026 results reflect a strong operational performance, with net operating revenues reaching $5.6 billion and consolidated adjusted EBITDA at $1.304 billion, representing a 23.2% margin. The company's ability to increase its revenue and cash flow guidance for the year is particularly noteworthy, especially in the face of challenges such as payer mix and insurance enrollment. Notably, the USPI segment contributed $542 million in adjusted EBITDA, driven by a 10% increase in same-store volume for total joint replacements, highlighting the company's operational strengths.
Tenet Healthcare is a Dallas-based healthcare services organization that operates acute and specialty hospitals, ambulatory surgery centers, and outpatient facilities across the United States. With a market capitalization of approximately $20.09 billion, Tenet is positioned within the healthcare sector, specifically in the Healthcare Providers & Services industry. The company is known for its comprehensive healthcare solutions, including revenue cycle management through its Conifer segment.
How Is THC Valued?
Currently, GF Valueā¢ data is not available for Tenet Healthcare. However, the company's P/E ratio stands at 8.99x, which is significantly lower than the historical median P/E ratio, suggesting that the stock may be undervalued relative to its earnings potential. Investors may find this valuation metric appealing as it indicates a potential opportunity for growth. For more detailed information, visit the THC stock page.
What Does THC's GF Scoreā¢ Tell Us?
The GF Scoreā¢ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Scoreā¢ values have been found to generate higher long-term returns (backtested 2006-2021).
| Metric | Rating |
|---|---|
| GF Scoreā¢ | 79 |
| Financial Strength | 5/10 |
| Profitability | 7/10 |
| Growth | 6/10 |
Tenet Healthcare's strengths lie in its profitability and growth metrics, with a profitability rank of 7/10 and a growth rank of 6/10. However, its financial strength is rated at 5/10, indicating some areas for improvement. The overall GF Scoreā¢ of 79 suggests that the company is well-positioned for long-term performance, although investors should remain cautious of its financial strength indicators. For further insights, visit the THC stock page.
What Are Insiders Doing with THC Stock?
In the past three months, insiders have sold $1.5 million worth of shares, with no purchases reported during the same period. This activity may suggest a cautious outlook among insiders regarding the company's future performance.
What This Means for Investors
Overall, Tenet Healthcare's strong Q2 results and increased guidance reflect a solid operational foundation, although insider selling may raise some concerns. The company's favorable GF Scoreā¢ and attractive P/E ratio indicate potential for growth, but investors should consider the financial strength metrics before making decisions. For the complete analysis, visit the THC stock page. You can also use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions
What is THC's GF Scoreā¢?
THC's GF Scoreā¢ is 79/100, indicating a strong potential for long-term performance based on various financial metrics.
How is THC valued?
THC has a P/E ratio of 8.99x, which suggests it may be undervalued compared to historical averages, offering potential for growth.
What is THC's P/E ratio compared to historical?
THC's current P/E ratio of 8.99x is lower than its historical median, indicating a potentially attractive valuation for investors.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
